Oscar Health, Inc. Wells Fargo raises target price to $27 from $20
OSCR•Related News
Lensar rises after surprise Q2 profit, revenue beat
LNSR•
Headwater Gold Signs New Earn-In Agreement With Newmont On The Jupiter Project, Nevada
NEM•
Cellectar Biosciences Q2 net loss widens on higher R&D costs
CLRB•
Accelerant Enters Into Definitive Agreement To Be Acquired By Thoma Bravo
ARX•
LENSAR Q2 revenue rises 18%, returns to profit
LNSR•